Building ties in pharma industry 'just like courtship'

[By The Straits Times]

The Straits Times sat down with our CEO, Dr Gideon Ho, to find out how Histoindex Pte Ltd's Genesis®200 system is breaking new grounds in developing drugs for liver conditions, particularly non-alcoholic steatohepatitis (NASH).